ONXX
ONXX Articles
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 –...
Published:
Last Updated:
These are some of the early bird analyst calls we are seeing from Wall Street analysts this Thursday morning: Ball Corporation (NYSE: BLL) Raised to Buy at Citigroup. Onyx Pharmaceuticals (NASDAQ:...
Published:
Last night was a novel release from the American Society of Clinical Oncology (or ASCO) as the society decided to publish all of the findings to the public at once. Keep in mind that many of the...
Published:
Last Updated:
The $8.8 Billion cash buyout of Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) has created a situation worth monitoring today. It isn’t just that this buyout could create a cascade of other...
Published:
Last Updated:
Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up $1.39 to $28.97,...
Published:
Antigenics Inc. (NASDAQ: AGEN) A study for Cancer vaccine, Oncophage, for the treatment of metastatic melanoma showed mixed results this morning. Shares are down almost 7% to $2.17. The 52 week...
Published:
These are not the only analyst calls that are impacting key shares today, but these are the top ten that 24/7 Wall St. is looking at as impact events on their own: Cbeyond Communications (CBEY)...
Published:
ACAD started as Hold at Citigroup.ALB raised to Neutral at Goldman Sachs.AMB raised to Buy at B of A.APD cut to Neutral at Goldman Sachs.BAC started as Buy at Goldman Sachs.BDN cut to Neutral at B of...
Published:
On today’s Stop Trading segment on CNBC, Jim Cramer said he was shocked that Revlimid from Celgene (CELG) was hardly noticed and he thinks it’s ready to run here. This down move in Celgene is a...
Published:
Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDN Jim Cramer has a video on TheStreet.com "Wall St. Confidential" showing how the biotech sector can be looked at with blow-ups. For every...
Published: